Time Magazine is slated to print a feature in its Feb. 27th edition that profiles the possible...

|By:, SA News Editor
Time Magazine is slated to print a feature in its Feb. 27th edition that profiles the possible benefits of Sequenom's (SQNM +0.2%) new product for testing a prenatal baby's DNA for Down syndrome. (sneak peek .pdf)